ANI Pharmaceuticals has again beat some analyst estimates, receiving praise at a transformative point for the company following its acquisition of Alimera Sciences earlier in autumn.
Notably, ANI managed to beat revenue estimates for the 10th straight quarter, per an 11 November H.C. Wainwright & CO...